apv30003 f pazjenti b esperjenza ta  impedituri protease fosamprenavir flimkien ma  doża baxxa ta  ritonavir jew darba kuljum (1400 mg/ 200 mg) (n=106) jew darbtejn kuljum (700 mg/ 100 mg) (n=106) flimkien ma  żewġ impedituri attivi ta  reverse transcriptase (rtis)